Here we report on the identification of DNA alterations in 13 primary SCLC using CGH. Consensus deletion regions were identified for chromosomes 3p, 5q, lOq, 13q, and 17p, whereas a consistent overrepresentation of chromosomes 3q, 5p, 8q, and 17q was observed. The SCLC specimens revealed 22 different amplified regions. The chromosomal mapping positions of these amplified sequences were determined after CGH on normal metaphase and prometaphase chromosomes.
MATERIALS AND MEmODS
Tumor Sampies. Tumor specimens (n = 13) were collected at postmortem examination 3-24 h after the patients died. One aliquot of the sampie was frozen in liquid nitrogen and kept at -80·C until DNA extraction. Genomic DNA was prepared by Proteinase K digestion and phenol-chloroform extraction (13) . A second aliquot was submitted to formalin fixation and paraffin embedding. The diagnosis of a SCLC was established in every case according to the WHO guidelines on hematoxylin and eosin-stained formalin-fixed tissue sections (14) . Multiple distant metastases were observed in 12 of 13 cases. One patient revealed only locallymph node metastases (case no. 11).
CGH Analysis. CGH analysis was done according to the protocol by Du Manoir et al. (2) with minor modifications. Genomic DNA from a healthy male donor was labeled in a standard nick translation reaction substituting dTI'P by digoxigenin-11-dUTP (Boehringer Mannheim); tumor DNA was labeled accordingly with biotin-16-dUTP (Boehringer Mannheim). The DNase I concentration in the labeling reaction was adjusted in order to reveal an average fragment size of 500-1 ()()() base pairs.
For COH, 200 ng of digoxigenin-labeled reference DNA and 200 ng of biotin labeled tumor DNA were ethanol precipitated in the presence of 10 ,..,g of salmon sperm DNA and 30 p,g of the Cotl fraction of human DNA (BRL).
This excess of Cotl DNA is required to prevent the ubiquitous hybridization of interspersed repetitive sequences contained in the tumor and reference DNA probes. The probe mixture was dried and resuspended in 10 ,..,1 hybridization solution [50% formamide, 2 X SSC (0.15M NaO, 0.015 M Na-citrate) and 10% dextran sulfate). The DNA was denatured at 76·C for 5 min and a1lowed to preanneal at 37·C for 60 min. Reference metaphase spreads were prepared following standard procedures from peripheral blood lymphocytes of a healthy donor (46,XX). The chromosome preparations were denatured separately at 80·C in 70% deionized formamide and 2 X SSC for 2 min and dehydrated through an ethanol series (70, 90, and 100%). The probe mixture was then applied to the denatured metaphase chromosomes under a coverslip (18 mm 2 ), sealed with rubber cement, and hybridized for 4 days at 37°C.
Posthybridization steps were performed as described (15) . The biotinylated sequences were detected with FITC conjugated to avidin (Vector laboratories). Probe sequences haptenized with digoxigenin were visualized with antidigoxigenin Fab fragments conjugated to rhodamine. Chromosomes were counterstained with DAPI and embedded in an antifading agent (DABCO; Sigma Chemical Co.) to reduce photobleaching. Dlgltallmage Analysis. F1uorescence was detected using a Zeiss Axiophot epifluorescence microscope. The f1uorescence banding pattern obtained after DAPI staining was used for chromosome identification. FITC and rhodamine f1uorescence, specific for the tumor and the reference genome, respectively, were quantified as gray level images by a charge-coupled device camera (Photometrics, Tucson, AZ). After background f1uorescence measurements, f1uorescence ratio images (Fig. 18) were calculated as described (2) . Tbe ratio profiles of individual reference chromosomes were determined by a program that was developed in our laboratory by S. du Manoir (5) certain chromosome. Thus, these values are 0.75 and 1. 25 , respectively. The curve shows the ratio profile !hat was cornputated as the mean value of live metaphase spreads. The gray boxes in Fig. 2 represent heterochromatic chromosome regions \hat cannot be interpreted. In these regions, very 10w ATC and rhodamine tluorescence intensities were recorded due to the suppression with Co! 1 DNA AccordingIy, Ouorescence raliai indicating copy number changes oould not be ca1culated. CGH experiments using, as the lest genome, DNA extracted from healthy donors versus the reference DNA used in these experiments did not result in values beyond the defined thresholds.
RESULTS
An example of the experimental data after CGH analysis of SCLC case no. 12 is presented in Figs. 1 and 2 . The f1uorescence banding pattern of a normallymphocyte metaphase spread after DAPI staining is shown in Fig. lA . This G-banding pattern was used for chromosome identification. Based on the values of the FITC and rhodamine f1uo-rescence, a ratio image was generated and is displayed using a look-up table (Fig. IB) . Blue indicates equal copy numbers in the two genomes. Green represents an overrepresentation in the tumor genome, while red is DNA loss. The loss of chromosome 3p is obvious. The frequently observed loss of chromosome 5q was accompanied by an overrepresentation of 5p. Furthermore, amplification sites could be mapped to chromosome bands 3q27-28, 19q13.1, and Xq27. The average f1uorescence profile that was calculated for each chromosome as the mean value of 5 metaphase spreads is exemplified for this case in Fig. 2 . Shaded areas represent regions rich in repetitive DNA in wh ich the profile could not be interpreted (see "Materials and Methods"). These average ratio profiles were used for the evaluation of chromosomal gains and losses in all cases.
An overview about all genetic alterations that were detected in 13 SCLCs is displayed in Fig. 3 . Vertical lines on the left side of each chromosome idiogram represent loss of genetic material in the tumor, whereas those on the right side correspond to again. Changes in individual cases can be identified by the case number provided on the top of each line. Amplification sites are represented as solid squares or bars.
Chromosome 3 was most frequently affected and showed alterations in all except one case (no. 1). Total or at least partialloss of the short arm was a consistent finding. Additionally, the long arm showed an overrepresentation in 10 cases. Chromosome 5 revealed genetic imbalances in 10 of 13 cases. Again, the loss of genetic material on one arm (5q) was often accompanied by a gain on the other chromosome arm (5p). This combination occurred in 45% of the cases (6 of 13). The results of CGH analysis were compared with studies of loss of heterozygosity with three markers on chromosome 3p located at 3p 13-14 (16) and 3p24 (17, 18) and two markers inside the APC gene that were assayed by PCR-RFLP (19) . In seven cases that were informative for these markers, the results were confirmed by CGHanalysis, e.g., values specific for DNA losses were consistent with LOH. In one case, however, LOH on chromosome 3p was not confirmed by CGH (see "Discussion"). Chromosome 8 was involved in 7 of 13 cases (54%). In five of these, an overrepresentation of the long arm was observed. The short arm of chromosome 17 was deleted in 8 axis for each chromosome in every metaphase, individual FITC and rhodamine of 13 cases (61 % ). profiles were calculated. These were used for the computation of the ratio Different amplification sites (n = 22) could be mapped to normal (F1TC:rhodamine) profiles. Theoretically, a monosomy of certain chromo-chromosomes. For high resolution mapping of the chromosomal 10-somes in the tumor would result in a ratio value of 0.5 and a trisomy in a value cation of the amplified regions, the CGH analysis was repeated on of 1.5. Values above 2 were regarded as amplified regions. The mean of the prometaphase chromosomes. Fig. 4 presents, as an example, a partial individual ratio profiles from five metaphase spreads were calculated (Fig. 2) . The three verticallines on the right side of the chromosome idiogram represent reference prometaphase spread with amplification sites visible at band different threshold values between the tumor and the reference DNA. The 8q24.1 harboring the c-myc protooncogene (case no. 3). Most frecentralline corresponds to a balanced state, as defined as the most frequently quently, chromosomal band 19q13. 1 was involved (4 cases). Seobserved value. The right and left Iines retlect the threshold values that would quences originating from chromosome bands 1 p32, 2p23, 7q 11.2, be present if 50% of the ceD popuJation carries either a monosomy or a trisomy for a 8q24, and 13q33-34 were each amplified in two cases. Amplification The ratio profile (curve) was calculated as a mean value of five metaphase spreads. Gray shaded bous, chromosomal regions rich in heterochromatin that could not be interpreted due to the abundance of highly repetitive DNA. All genetic changes that were visible in Fig. 18 were confirmed after mean ratio profile measurements.
sites that occurred only once were observed at the following locations: lq24, lq32, 3q27-28, 5p15, 5p14, 6q21, 6q25, 8q21, 9q22, llql3, 12p, 14q12-21, 15q24-25, 21q21, 22ql1.2, Xpl1.2, and Xq. DISCUSSION CGH has recently evolved as a powerful tool for the identification of chromosomal gains and losses in genomic DNA from tumor sam pIes (1-6). Using CGH, we identified numerous chromosomal gains and losses as weIl as DNA amplification sites in 13 cases of primary SCLC.
Lass of genetic material was observed in decreasing frequency on chromosomes 3p, 5q, 17p, l3q, IOq, and 4q (Fig. 3) . Most consistently, a loss of the short arm of chromosome 3 was observed in 90%. This is also the most consistent finding that has been reported previously by means of cytogenetical (20-24) and molecular biology studies involving RFLP markers (25) . In one case, the deleted region were reported previously in cytogenetic analysis of SCLC, although was restricted to chromosomal bands 3pI2-21.2. However, in the less frequently than in our series of SCLe (27) . The fact that, in majority of cases the entire short arm was underrepresented. In 10 addition to values reflecting a gain of 3q and 5p, amplification sites cases, we observed a simultaneous overrepresentation of the long arm. were mapped to these chromosome arms might favor the hypothesis Such a result would be expected in case of an isochromosome 3q that not only the loss of heterozygosity on 3p and 5q but also the low formation. Isochromosomes are the cytogenetic correlate of low level level amplification of certain genes on 3q and 5p are important events amplification of many genes which might induce a growth advantage in tumor initiation. important for tumor initiation (26) . Chromosome 5 frequently showed
The frequent deletions of chromosomes 3p and 5q in SCLe are a similar pattern, i.e., the gain of the short arm was accompanied by indicative for a pivotal mutation in tumor formation. 80th chromethe loss of 5q in six cases. This result is suggestive for an isochro-somal arms harbor at least one tumor suppressor gene, i.e., the von mosome 5p. 80th an isochromosome 3q and an isochromosome 5p Hippel-Lindau gene on 3p25-26 and the FAP gene on 5q (28-30). Tbe contradictory results for loss of 3p material using CGH and PCR-RFLP analysis, wh ich we observed in one case (no. 1), can be explained by several cytogenetic events: (a) smalI, submicroscopical deletions which are beyond the resolution of CGH on metaphase chromosomes; (b) mitotic recombination; and (c) chromosome loss that was followed by reduplication (31) . 80th mitotic recombination and reduplication would result in LOH and uniparental disomy that would not be accompanied by copy number changes detectable with CGH. We observed LOH with primers for chromosomal bands 3p14 and 3p24. Adeletion of that size would be c1early detectable by CGH. Tbus, mitotic recombination or cbromosome reduplication appear to be the more Iikely mechanisms that account for the described discrepancy. In all other cases (nos. 3-5, 7-9, and 13) wbere LOH studies were informative (19) , the results were consistent with the CGH analysis.
Tbe tumor suppressor genes p53 and RB are located on chromosomes 17p and 13q, respectively (32) . We observed partial and complete DNA loss on these chromosomal arms in 8 of 13 (62%) and 7 of 13 (54%) cases. Tbe chromosome 13 losses were invariably accompanied with underrepresentation for 17p. 80th chromosomal loci are subject to allelic loss in SCLC as determined by LOH studies using RFLPs (33) . An additional consensus region involved in losses was observed on the chromosomal band IOq24-25 in 5 of 13 cases. Tbis region has not been reported previously to be deleted in lung cancer but is known to reveal LOH in e.g., gIioblastoma and renal cell carcinoma (12) . Loss of IIp was not observed in our collective, in contrast to previous LOH studies (12) . Additional DNA losses were found on chromosomes 2p, 4, 8p, 9q, 16, llq, 12q, 18p, 2Op, 21, and 22.
Tbe pattern of chromosomal gains and losses in SCLCs is very complex and involves virtually every si te in the genome. Tbis indicates a high genomic instability. Some chromosomes (e.g., 9, 13,21, and 22) were involved in both gains and losses of the same subregions. Tbis could possibly be explained as the result of random cbromosomal changes which occur early in tumor development. Such random changes would be present in the predominant c1one(s) and thus could be detected by CGH. However, some chromosomal sites were involved with much higher frequencies tban others (see above), indicating their specific role in these tumors. It is a striking observation that chromosome arms 3p, 5q, IOq, and 17p and chromosome bands 4q31-35, which were commonly deleted in these tumors, were never involved in gains of genetic material. From these data, it appears that random gains of these chromosome segments would be prohibitive with regard to the formation of SCLCs. An interesting observation in this respect was reported by Satoh et al. (34) ; the tumorigenic potential of a lung adenocarcinoma cell line was suppressed after the introduction of chromosomes 3 and 11 by means of cell fusion experiments.
Amplification of protooncogenes are a common feature of solid tumors (35, 36) . A cytogenetic correlate is provided by double minute chromosomes or homogeneously staining regions. In contrast to deleted regions, amplifications usually reflect advanced and more aggressive tumor stages. In SCLC, amplification of the myc protooncogene family has been reported (37) (38) (39) . We mapped the origin of amplicons to chromosome bands Ip31-32 (case nos. 3 and 7), 8q24 (case nos. 3 and 11), and 2p23 (case nos. 6 and 8). Tbese sites harbour the L-myc, N-myc, and c-myc protooncogenes, respectively (40) . Additionally, amplified regions were mapped to chromosomal sites containing genes of the ras family, i.e., 12p ). An additional site which showed overrepresentation in 4 of 13 cases was identified on chromosome 19q13.1. To our knowledge, no protooncogene has been mapped so far to this chromosome band. Candidate genes include the gene for the transforming growth factor (41) and a zinc finger gene (42) . Tbe possible involvement of these genes can now be tested by means of Southern blot analysis or PCR analysis.
Recent progress in solid tumor molecular biology, e.g., the identification of the gene for the familiar tumor syndrome von HippelLindau (30) and the F AP gene (28, 29) , was achieved by positional cloning techniques. Tbe identification of the chromosomal mapping position of commonly deleted or amplified loci in SCLC, as exemplified in this study, will streamline cloning efforts considerably. Future work will be focused on the identification of genetic changes specific for certain histologically defined lung cancers. Also, CGH of a higher case number, including primary tumors and metastatic sites, should contribute to identify those genetic aberrations that are responsible for a more aggressive c1inical course, including the potential for metastasis.
